Momentum Is Back At Cipla In Q2

05:58 EST 8 Nov 2019 | SCRIP

Cipla had a strong run across key businesses in Q2, with products like generic Sensipar retaining share in the US...


Related Stories


Original Article: Momentum Is Back At Cipla In Q2


More From BioPortfolio on "Momentum Is Back At Cipla In Q2"

Quick Search

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...